MoonLake
Andrew Jones is currently serving as the Director Clinical Operations at MoonLake Immunotherapeutics. Prior to his current role, he held positions at Evelo Biosciences, UCB, Daiichi Sankyo UK Ltd, Novartis, and Simbec Research Ltd, showcasing his expertise in project management of clinical studies across various phases. Andrew holds an MSc in Clinical Research from Cardiff University and a BSc (Hons) in Science in Health Exercise and Sport from University Wales Institute of Cardiff.
This person is not in any offices
MoonLake
2 followers
MoonLake Immunotherapeutics AG is a clinical-stage biopharmaceutical company leveraging revolutionary Nanobody® technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.